Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Enlivex Ltd. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q4 2024
- Shares held
- 3.17M
- −237.4K (−7.0%) vs. Q4 2024
- Total value
- $3.08M
- −$910.5K (−22.8%) vs. Q4 2024
- New holders
- 4
- 5 more added
- Sold out
- 2
- 7 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,781,931 | $1.73M | 0.05% | −426,069−19.3% | Reduced |
| Millennium Management LLC | 669,008 | $649.1K | 0.00% | +35,161+5.5% | Added |
| Morgan Stanley | 230,685 | $223.8K | 0.00% | −38,970−14.5% | Reduced |
| Renaissance Technologies LLC | 181,289 | $175.9K | 0.00% | +22,297+14.0% | Added |
| Jane Street Group, LLC | 80,759 | $78.4K | 0.00% | +67,886+527.4% | Added |
| Citadel Advisors LLC | 70,136 | $68.0K | 0.00% | +70,136 | New |
| Two Sigma Securities, LLC | 28,390 | $27.5K | 0.00% | +6,028+27.0% | Added |
| Sigma Investment Counselors Inc | 28,000 | $27.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 17,451 | $17.0K | 0.00% | +17,451 | New |
| Neuberger Berman Group LLC | 14,000 | $13.6K | 0.00% | +14,000 | New |
| Susquehanna International Group, LLP | 10,833 | $10.5K | 0.00% | −326−2.9% | Reduced |
| Geode Capital Management, LLC | 10,420 | $10.1K | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 10,000 | $10.0K | 0.00% | +10,000 | New |
| HRT Financial LP | 10,178 | $9.00K | 0.00% | −6,700−39.7% | Reduced |
| Wells Fargo & Company | 9,184 | $8.91K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,737 | $6.53K | 0.00% | +6,026+847.5% | Added |
| Signaturefd, LLC | 5,000 | $4.85K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,500 | $2.43K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,913 | $1.86K | 0.00% | −651−25.4% | Reduced |
| Simplex Trading, LLC | 1,063 | $1.00K | 0.00% | −2,303−68.4% | Reduced |
| SRS Capital Advisors, Inc. | 1,015 | $985 | 0.00% | 00.0% | Unchanged |
| BFSG, LLC | 1,000 | $971 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1,000 | $970 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 220 | $213 | 0.00% | −834−79.1% | Reduced |
| Red Tortoise LLC | 150 | $146 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 16 | $16 | 0.00% | 00.0% | Unchanged |
| ARS Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |